Literature DB >> 18314929

Management of early rectal cancer.

M G Tytherleigh1, B F Warren, N J McC Mortensen.   

Abstract

BACKGROUND: Early rectal cancer (ERC) is adenocarcinoma that has invaded into, but not extended beyond, the submucosa of the rectum (that is a T1 tumour). Local excision is curative for low-risk ERCs but for high-risk cancers such management is controversial.
METHODS: This review is based on published literature obtained by searching the PubMed and Cochrane databases, and the bibliographies of extracted articles. RESULTS AND
CONCLUSION: ERC presents as a focus of malignancy within an adenoma, as a polyp, or as a small ulcerating adenocarcinoma. Preoperative staging relies on endorectal ultrasonography and magnetic resonance imaging. Pathological staging uses the Haggitt and Kikuchi classifications for adenocarcinoma in pedunculated and sessile polyps respectively. Lymph node metastases increase with the Kikuchi level, with a 1-3 per cent risk for submucosal layer (Sm) 1, 8 per cent for Sm2 and 23 per cent for Sm3 lesions. Low-risk ERCs may be treated endoscopically or by a transanal procedure. Transanal excision or transanal endoscopic microsurgery may be inadequate for high-risk ERCs and adjuvant chemoradiotherapy may be appropriate. There is a low rate of recurrence after local surgery for low-risk ERCs but this increases to up to 29 per cent for high-risk cancers. 2008 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2008        PMID: 18314929     DOI: 10.1002/bjs.6127

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  41 in total

1.  Treatment of early rectal cancer.

Authors:  I Kesisoglou; K Sapalidis
Journal:  Tech Coloproctol       Date:  2010-11       Impact factor: 3.781

2.  Proximal and distal rectal cancers differ in curative resectability and local recurrence.

Authors:  Wasantha Wijenayake; Mahendra Perera; Jayantha Balawardena; Raeed Deen; S Ruwan Wijesuriya; Sumudu K Kumarage; Kemal I Deen
Journal:  World J Gastrointest Surg       Date:  2011-08-27

Review 3.  [Management of complications in anal and transanal tumor surgery].

Authors:  M Sailer; S Eisoldt; C Möllmann
Journal:  Chirurg       Date:  2015-08       Impact factor: 0.955

4.  Endoscopic Resection of Malignant Colonic Polyps: Why Clinicopathological Correlation (CPC) Is Needed for Optimal Treatment of CRC?

Authors:  David F Schaeffer; Fergal Donnellan
Journal:  Dig Dis Sci       Date:  2015-09       Impact factor: 3.199

5.  MRI surveillance for the detection of local recurrence in rectal cancer after transanal endoscopic microsurgery.

Authors:  Britt J P Hupkens; Monique Maas; Milou H Martens; Willem M L L G Deserno; Jeroen W A Leijtens; Patty J Nelemans; Frans C H Bakers; Doenja M J Lambregts; Geerard L Beets; Regina G H Beets-Tan
Journal:  Eur Radiol       Date:  2017-06-30       Impact factor: 5.315

6.  Confocal chromolaser endomicroscopy: a supplemental diagnostic tool prior to transanal endoscopic microsurgery of rectal tumors?

Authors:  Thomas Borschitz; Ralf Kiesslich
Journal:  Int J Colorectal Dis       Date:  2009-11-04       Impact factor: 2.571

7.  A computer-aided algorithm to quantitatively predict lymph node status on MRI in rectal cancer.

Authors:  D M L Tse; N Joshi; E M Anderson; M Brady; F V Gleeson
Journal:  Br J Radiol       Date:  2012-09       Impact factor: 3.039

8.  Malignant colorectal polyps.

Authors:  Luis Bujanda; Angel Cosme; Ines Gil; Juan I Arenas-Mirave
Journal:  World J Gastroenterol       Date:  2010-07-07       Impact factor: 5.742

9.  Perforation into the peritoneal cavity during transanal endoscopic microsurgery for rectal cancer is not associated with major complications or oncological compromise.

Authors:  Gunnar Baatrup; Thomas Borschitz; Christoffer Cunningham; Niels Qvist
Journal:  Surg Endosc       Date:  2009-01-27       Impact factor: 4.584

10.  Poorly differentiated clusters (PDCs) as a novel histological predictor of nodal metastases in pT1 colorectal cancer.

Authors:  Valeria Barresi; Giovanni Branca; Antonio Ieni; Luca Reggiani Bonetti; Luigi Baron; Stefania Mondello; Giovanni Tuccari
Journal:  Virchows Arch       Date:  2014-04-27       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.